This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.

Questa invenzione riguarda l'uso di un gruppo delle uree ariliche nelle malattie mediate cytokine trattanti tranne cancro e nelle malattie mediate enzima proteolitico tranne cancro e le composizioni farmaceutiche per uso in tale terapia.